ChemicalBook > Product Catalog >API >Antiallergic drugs >Antihistamines >Azelastine

Azelastine

Azelastine Structure
CAS No.
58581-89-8
Chemical Name:
Azelastine
Synonyms
-4-yl)-;AZELASTINE;SPBio_000657;KBio3_002992;CAS 790307-93-0;Azelastine base;Spectrum3_001984;Spectrum2_000649;Azeptin:Rhino1ast;Azelastine USP/EP/BP
CBNumber:
CB6256007
Molecular Formula:
C22H24ClN3O
Molecular Weight:
381.9
MOL File:
58581-89-8.mol
Modify Date:
2024/3/19 15:37:50

Azelastine Properties

Melting point 111 - 115°C
Boiling point 533.9±60.0 °C(Predicted)
Density 1.1505 (rough estimate)
refractive index 1.5790 (estimate)
storage temp. 2-8°C
solubility Chloroform (Slightly), DMSO (Slightly, Heated), Methanol (Slightly)
pka pKa 9.82(H2O t=25 I=0.025) (Uncertain)
form Solid
color White to Off-White
BCS Class 1?
Stability Stable under recommended storage conditions., Stable Under Recommended Storage C
CAS DataBase Reference 58581-89-8(CAS DataBase Reference)

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H315-H312-H302-H335-H332
Precautionary statements  P264-P280-P302+P352-P321-P332+P313-P362-P261-P271-P304+P340-P312-P280-P302+P352-P312-P322-P363-P501-P264-P270-P301+P312-P330-P501
Toxicity LD50 orl-rat: 310 mg/kg ARZNAD 31,1184,81

Azelastine Chemical Properties,Uses,Production

Uses

anesthetic, anticonvulsant

Definition

ChEBI: A phthalazine compound having an oxo substituent at the 1-position, a 1-methylazepan-4-yl group at the 2-position and a 4-chlorobenzyl substituent at the 4-position.

Clinical Use

Azelastine, although not a close structural analogue to the benzimidazoles, has some structural similarities to them. It is used as a nasal spray for allergic rhinitis and as eye drops for allergic conjunctivitis.Like olopatadine, azelastine also stabilizes mast cells, preventing degranulation and subsequent release of histamine, leukotrienes, and PGD2. It is available in Europe for systemic use in the treatment of asthma and seasonal allergies. Besides antihistaminic effects, it also may block release of histamine and other inflammatory mediators from mast cells. When administered orally, the N-dealkylated metabolite appears to contribute significantly to its pharmacological effects.

Safety Profile

Poison by ingestion,subcutaneous, intravenous, and intraperitoneal routes.Experimental reproductive effects. When heated todecomposition it emits toxic fumes of NOx and Cl- .

Azelastine Preparation Products And Raw materials

Global( 147)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Anant Pharmaceuticals Pvt Ltd +91-8550986868 +91-9485998001 Haryana, India 461 58 Inquiry
Ralington Pharma +91-7948911722 +91-9687771722 Gujarat, India 1350 58 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
A.J Chemicals 91-9810153283 New Delhi, India 6124 58 Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6773 58 Inquiry
Unitrade Agencies 08048372548Ext 632 Mumbai, India 197 58 Inquiry
Triveni chemicals 08048762458 New Delhi, India 6093 58 Inquiry
Pharma Affiliates 172-5066494 Haryana, India 6761 58 Inquiry
Henan Tianfu Chemical Co.,Ltd. +86-0371-55170693 +86-19937530512 China 21675 55 Inquiry
career henan chemical co +86-0371-86658258 +8613203830695 China 29900 58 Inquiry

Azelastine Spectrum

1(2h)-phthalazinone,4-((4-chlorophenyl)methyl)-2-(hexahydro-1-methyl-1h-azepin 4-(p-chlorobenzyl)-2-(hexahydro-1-methyl-1h-azepin-4-yl)-1-(2h)-phthalazinon 4-(4-chlorobenzyl)-2-(1-methylazepan-4-yl)phthalazin-1(2H)-one hydrochloride 4-(4-chlorobenzyl)-2-(1-methylazepan-4-yl)phthalazin-1-one 4-[(4-chlorophenyl)methyl]-2-(1-methyl-4-azepanyl)-1-phthalazinone 4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)phthalazin-1(2H)-one Azelastinum [INN-Latin] KBio3_002992 SPBio_000657 Spectrum2_000649 Spectrum3_001984 -4-yl)- AZELASTINE 1(2H)-Phthalazinone, 4-[(4-chlorophenyl)methyl]-2-(hexahydro-1-methyl-1H-azepin-4-yl)- 4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)-phthalazin-1-one CAS 790307-93-0 Azeptin:Rhino1ast 2-(Hexahydro-1-methyl-1H-azepin-4-yl)-4-[(4-chlorophenyl)methyl]phthalazin-1(2H)-one 4-(p-Chlorobenzyl)-2-(1-methylhexahydro-1H-azepin-4-yl)phthalazin-1(2H)-one 4-(p-Chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1(2H)-phthalazinone Azelastine & Azelastine Hydrochloride Azelastine base 4-[(4-chlorophenyl)Methyl]-2-[(4S)-1-Methylazepan-4-yl]-1,2-dihydrophthalazin-1-one 4-[(4-chlorophenyl)methyl]-2-(hexahydro-1-methyl-1H-azepin-4-y1)-1(2H)-phthalazinone 4-(4-Chlorobenzyl)-2-(1-methylazepan-4-yl)phthalazin-1(2H)-one 4-((4-Chlorophenyl)methyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1(2 4-[(4-chlorophenyl)methyl]-2-[(4S)-1-methyl-4-azepanyl]-1-phthalazinone Azelastine USP/EP/BP Phenylpyruvic Acid Impurity 7 58581-89-8 53408-27-6 C22H26ClN3O TELAZOL API